Insider · CIK 0001517718
Geoffrey Michael Glass
Files at AVDL (AVADEL PHARMACEUTICALS PLC). First filing Dec 10, 2024, latest Dec 10, 2024.
Geoffrey Michael Glass files SEC Form 4 as director at AVDL (AVADEL PHARMACEUTICALS PLC). Since Dec 10, 2024, Geoffrey Michael Glass has reported 1 open-market buy worth $200k and 0 open-market sells worth $0, the latest filed on Dec 10, 2024.
A track record needs three past buys with six months of prices behind them; Geoffrey Michael Glass has 0, so none is measured yet.
The newest scored trade: bought $200k of AVDL on Dec 10, 2024, filed Dec 10, 2024, scored 48 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | AVADEL PHARMACEUTICALS PLC | $200k 20,279 shares | +34% | - |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Ordinary Shares | -22,005 | $21.00 | $462k | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Ordinary Sharesindirect: By Trust | -69,075 | $21.00 | $1.5M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Ordinary Sharesindirect: By Trust | -75,904 | $21.00 | $1.6M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -60,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -33,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -11,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -11,000 | - | - | 0 | Feb 12, 2026 |
| Sep 15, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | GGift Stock Option (Right to Buy)derivative | -11,000 | $0.00 | $0 | 0 | Sep 15, 2025 |
| Jul 29, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | AGrant or award Ordinary Shares | +11,000 | $0.00 | $0 | 22,000 | Jul 31, 2025 |
| Jul 29, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | AGrant or award Stock Option (Right to Buy)derivative | +11,000 | $0.00 | $0 | 11,000 | Jul 31, 2025 |
| Dec 10, 2024 | AVDL AVADEL PHARMACEUTICALS PLC | POpen-market purchase Ordinary Sharesindirect: By Trust | +10,075 | $9.89 | $100k | 69,075 | Dec 10, 2024 |
| Dec 10, 2024 | AVDL AVADEL PHARMACEUTICALS PLC | POpen-market purchase Ordinary Sharesindirect: By Trust | +10,204 | $9.80 | $100k | 75,904 | Dec 10, 2024 |
Questions about Geoffrey Michael Glass
Answered from the filings on this page, as of the latest one.
Is Geoffrey Michael Glass buying or selling?
Not in the last 12 months. Geoffrey Michael Glass's latest open-market trade on SEC Form 4 was bought $200k of AVDL on Dec 10, 2024.
How did Geoffrey Michael Glass's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Geoffrey Michael Glass has 0.
Where does Geoffrey Michael Glass file Form 4?
Geoffrey Michael Glass has filed Form 4 at AVDL (AVADEL PHARMACEUTICALS PLC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.